Puma Biotech Shares Slide On Secondary Stock Offering

By Markets MarketWatch Pulse

Puma Biotechnology Inc. shares fell in the extended session Tuesday after the biotech said it was launching a secondary public offering of its shares. Puma shares fell 4.8% to $50.15 after hours. The company said it planned to sell $150 million in shares, with an additional $22.5 million to underwriters to cover overallotments. Citigroup and J.P. Morgan are the lead book-running managers. At Tuesday's closing price, the offering including overallotments works out to about 3.3 million shares. Puma has about 32.5 million shares outstanding, according to FactSet data.

Continue Reading Below

Copyright © 2016 MarketWatch, Inc.